戻る
CNS Pharmaceuticals Inc (CNSP)価格
CNSP 株価推移チャート
CNSP 収入
CNS Pharmaceuticals Inc
$7.04
-4.47%
$-0.33
終値： Jan 16, 16:00:00 GMT-5
$6.62
-5.85%
$-0.41
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$7.37
始値
$6.91
当日レンジ
$6.62 - $7.39
52週レンジ
$4.93 - $114
取引高
67.5K
平均取引高
37.3K
1株当たり利益(TTM)
-130.84
配当利回り
--
時価総額
$4.1M
CNSPとは何ですか？
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. The company is headquartered in Houston, Texas and currently employs 4 full-time employees. The company went IPO on 2019-11-08. The firm's drug candidate, Berubicin, is the first anthracycline to appear to cross the blood-brain barrier. Berubicin is the subject of the Company's late-stage, fully-enrolled, global clinical trial for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. The firm's drug candidate, TPI 287, is an abeotaxane which stabilizes microtubules and inhibits cell division, causing apoptosis and cell death. TPI 287 has shown the potential to cross the blood-brain barrier and treat central nervous system (CNS) tumors.